Researchers Highlight Tau and Blood‑Brain Barrier Advances at Alzheimer’s Conference

STAT’s AAIC in 30 newsletter reported that tau protein remains the central focus of Alzheimer’s research presented at the recent conference in London. Scientists discussed new strategies aimed at delivering therapeutic agents across the blood‑brain barrier, a long‑standing challenge in neurodegenerative disease treatment.

The piece was authored by Andrew Joseph, a Europe correspondent for STAT, who noted the lively atmosphere of the meeting and encouraged attendees to explore the city. He also invited readers to share questions via his confidential Signal contact.

STAT promoted a special report on dementia diagnostics, treatments, and care, offering a discounted download code for subscribers. The newsletter serves as a brief snapshot of the conference’s key scientific themes for pharma professionals and investors.